Natural Biocon (India) Ltd (543207)
சுருக்கம்
The board meets on 14 Nov 2026 to consider the Q2 FY27 results.
நிகழ்வுகள்
- அடுத்த முடிவுகள்
- 14 நவ. 2026 (Q2 FY27)
- சமீபத்திய முடிவுகள்
- Q1 FY27, தாக்கல் செய்யப்பட்டது 27 அக். 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 5 செப். 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
📅 அடுத்த நிதி முடிவுகள்: 14 நவ. 2026 (இயக்குநர் குழுக் கூட்டம்)Natural Biocon (India) Ltd-இன் இயக்குநர் குழுக் கூட்டம் 14 நவ. 2026 அன்று நடைபெறுகிறது; அதில் அதன் Q2 FY27 முடிவுகள் பரிசீலிக்கப்படும் (ஜூலை-செப்டம்பர் 2026).
In its latest reported quarter, Q1 FY27, Natural Biocon's revenue was ₹0.0 Cr (-100.0% year on year, -100.0% on the previous quarter), and net profit ₹-0.0 Cr (against a profit a year earlier).
| Q1 FY27 (₹ கோடி) | மதிப்பு | YoY Q1 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹0.0 | -100.0% | -100.0% |
| செயல்பாட்டு லாபம் | ₹-0.0 | நஷ்டமாக | நஷ்டம் குறைந்தது |
| நிகர லாபம் | ₹-0.0 | நஷ்டமாக | நஷ்டம் குறைந்தது |
| EPS (₹) | 0.00 | -100.0% | நஷ்டம் குறைந்தது |
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
Natural Biocon (India) Ltd announced that its Board of Directors accepted the resignations of Managing Director Arunkumar Dashrathbhai Prajapati and Company Secretary Shruti Sharma, both effective retrospectively from September 26, 2026. Additionally, the Board decided to cancel and withdraw previous disclosures regarding the appointments of two Independent Directors (effective June 6, 2026) and the AGM Scrutinizer. This leadership vacuum hits a micro-cap company with a market cap of just Rs 5 Cr and a declining revenue base (FY26 revenue fell to Rs 2.55 Cr with an annual net loss of Rs 0.03 Cr).
- Resignation of Managing Director Arunkumar Dashrathbhai Prajapati effective 26 September 2026
- Resignation of Company Secretary Shruti Sharma effective 26 September 2026
- Cancellation/withdrawal of appointments for 2 Additional Independent Directors originally effective 06 June 2026
- Withdrawal of disclosure regarding appointment of Scrutinizer for AGM e-voting
- Micro-cap context: market capitalization stands at Rs 5 Cr with FY26 revenue of Rs 2.55 Cr
Natural Biocon (India) Ltd announced that its Managing Director, Arun Kumar Dashrathbhai Prajapati, has resigned from the board effective close of business hours on September 26, 2026. The cited reason is increased professional commitments and time constraints, with no other material reasons reported. The departing Managing Director holds NIL shares in the micro-cap company (market cap Rs 5 Cr). This leadership exit occurs as the company operates at a modest scale, generating TTM revenue of just Rs 3 Cr.
- Managing Director Arun Kumar Dashrathbhai Prajapati resigned with effect from September 26, 2026
- Reason cited is increased professional commitments and time constraints
- Outgoing Managing Director holds NIL shares in the company
- Departure comes amidst micro-cap scale with Rs 5 Cr market cap and TTM revenue of Rs 3 Cr
Natural Biocon (India) Ltd announced the outcome of its Board meeting held on September 05, 2026. The Board approved convening the 34th Annual General Meeting (AGM) on September 30, 2026, via Video Conferencing, with share transfer books closed from September 24 to September 30, 2026. Additionally, the Board formalized the appointment of two Additional Independent Directors (Mrs. Tapasya Sheth and Mrs. Minaben Shah) and accepted the resignation of Company Secretary Mr. Gopal Trivedi, all effective June 06, 2026.
- 34th Annual General Meeting scheduled for September 30, 2026, at 11:30 AM IST via VC
- Share transfer books and Register of Members to remain closed from September 24 to September 30, 2026
- Appointed Mrs. Tapasya Sheth and Mrs. Minaben Shah as Non-Executive Independent Directors w.e.f. June 06, 2026
- Noted resignation of Mr. Gopal Trivedi as Company Secretary and Compliance Officer w.e.f. June 06, 2026
Natural Biocon (India) Ltd reported zero operational revenue for the quarter ended June 30, 2026, down from ₹166.57 lakh in the corresponding quarter of the previous year. The company posted a net loss of ₹1.16 lakh compared to a net profit of ₹13.86 lakh in Q1 FY26. Total expenses declined sharply to ₹1.16 lakh (vs ₹152.71 lakh in Q1 FY26) due to the absence of trading and purchase activity. Additionally, the board approved the resignation of statutory auditor M/s Mayur Shah & Associates and appointed M/s Nirav S Shah & Co.
- Revenue from operations was ₹0.00 lakh vs ₹166.57 lakh in Q1 FY26
- Net loss stood at ₹1.16 lakh against a net profit of ₹13.86 lakh in Q1 FY26
- Total expenses dropped to ₹1.16 lakh compared to ₹152.71 lakh in the previous year quarter
- Paid-up equity share capital stood unchanged at ₹2,578.28 lakh
- M/s Nirav S Shah & Co appointed as Statutory Auditors w.e.f. August 1, 2026 following resignation of M/s Mayur Shah & Associates
Natural Biocon (India) Ltd has scheduled a board meeting for August 14, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. A significant agenda item is the resignation of the current statutory auditors, M/s Mayur Shah & Associates, and the proposed appointment of M/s Nirav S Shah & Co. Given the company's micro-cap status (Rs 7 Cr) and low promoter holding of 9.4%, the reasons behind the auditor change are critical for investors to monitor. The company reported a revenue of Rs 2.55 Cr in FY26, a sharp decline from Rs 8.35 Cr in FY25.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
- Resignation of M/s Mayur Shah & Associates as Statutory Auditors to be noted
- Proposed appointment of M/s Nirav S Shah & Co as the new Statutory Auditors
- Company market capitalization stands at a low Rs 7 Cr
- Promoter holding is notably low at 9.4% as of March 2026
Natural Biocon (India) Ltd has announced the immediate resignation of two directors, Mrs. Tapasya Sheth and Mrs. Minaben Shah, effective July 14, 2026. The board meeting to approve these exits was conducted and concluded within 45 minutes. This management change occurs against a backdrop of significant share price erosion, with the stock down 70.3% over the last 12 months. No specific reasons for the resignations were disclosed in the filing.
- 2 directors, Mrs. Tapasya Sheth and Mrs. Minaben Shah, resigned effective July 14, 2026
- The board meeting lasted 45 minutes, starting at 12:00 p.m. and concluding at 12:45 p.m.
- Company stock has experienced a 70.3% price decline over the past 12 months
- The resignations were accepted and approved in the board meeting held on July 14, 2026
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
